Release Date: 10/05/2021
Expiration Date: 10/05/2022
Learner Notification
*Please note that you must complete the Post Webinar Evaluation (link below) to receive CE credit.

Carol Iddins, MD, FAADM
Radiation Emergency Assistance Center/Training Site
Oak Ridge Institute for Science and Education
Has disclosed no relevant financial relationships

Emily Kiernan, DO
Associate Professor
Medical Toxicologist
Emory University School of Medicine
Department of Emergency Medicine
Has disclosed no relevant financial relationships

Shawn M. Varney, MD, FAACT, FACEP, FACMT
Professor of Emergency Medicine
Medical Director, South Texas Poison Center
University of Texas Health Science Center San Antonio
Has disclosed no relevant financial relationships

Summary: Americium is a man-made, radioactive element that undergoes alpha decay and is capable of damaging biological cells. Fortunately, alpha particles are unable to penetrate the skin sufficiently to impact cells dangerously, but internal contamination carries a greater risk level. Since americium’s isotopes are used to make common household products like smoke detectors, inadvertent exposures to may occur. It is important for toxicologists to be familiar with americium and its isotopes to provide appropriate decontamination and treatment guidelines. This webinar will discuss properties of americium relevant to the medical management of an incident involving americium, as well as describe the indications, mechanism of action, and dosing of diethylenetriamine pentaacetate (DTPA) in treating patients after an americium exposure.

Objectives for Webinar:
1. Discuss properties of americium relevant to the medical management of an incident involving americium.
2. Discuss the indications, mechanism of action, and dosing of DTPA in treating americium exposures.
3. Describe a case to reinforce the learner’s understanding.

Physicians & Pharmacists
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and the American Academy of Clinical Toxicology. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation Statement
Amedco LLC designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 CreditsTM for physicians and 1.00 knowledge-based contact hours for pharmacists. Learners should claim only the credit commensurate with the extent of their participation in the activity. UAN: JA4008163-9999-21-198-H04-P.

NOTE TO PHARMACISTS: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 30 days of completion to meet the deadline for submission to CPE Monitor.

Method of Physician Participation
Learners will listen to each audio self-directed module while following along with the visual slides. Upon completion, each learner will answer evaluation questions to receive their CME certificate.


Click here to complete the Post Webinar CE Evaluation

Click here to return to Section Webinar Listing

Member Account